Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours Β· Estimated delivery Sep 28 - Oct 3
Semaglutide is an active ingredient in the popular weight loss medication, Wegovy
The impact of alternative risk of complications methodology was assessed across a range of analyses
Considerations for specific populations: Individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasias should avoid these medications Pregnant or nursing women are advised not to use semaglutide or Zepbound Those with a history of pancreatitis, certain thyroid cancers, or a slow digestive system should exercise caution While Zepbound may potentially present more frequent or severe side effects due to its higher potency, the overall risk profile is similar to that of semaglutide
Wegovy.com Official US Prescribing Information (2026) The content on the SheMed blog is provided for general informational and educational purposes only
US$ 25.84
US$ 24.90
US$ 28.32
